Baidyanath Prostaid Tablets
Original price was: $10.35.$9.85Current price is: $9.85.
Baidyanath Purnachandra Ras Each Tablets (40 tablets)
Original price was: $8.90.$8.45Current price is: $8.45.
-5%
Baidyanath Punarnawadi Mandur Tablet (30 tablets)
Baidyanath Punarnawadi Mandur Tablet — a herbal preparation crafted to traditional ayurvedic standards, quality-checked at every stage.
Original price was: $8.20.$7.80Current price is: $7.80.
Description
Baidyanath Punarnawadi Mandur Tablet (30 tablets) is a herbal preparation from Baidyanath, made to traditional standards and crafted using traditional herbal and ayurvedic methods.
Composition
Herbal / ayurvedic formulation. Please refer to the product pack for the full list of ingredients.
Presentation
Tablets form, carefully manufactured and quality-checked at every stage.
Directions for Use
Use as directed on the pack, or as advised by a qualified healthcare practitioner.
Safety Information
Keep out of reach of children. Store in a cool, dry place away from direct sunlight and moisture.
Specification
![]()
Overview
| Brand | Baidyanath |
|---|---|
| Formulation | Tablet |
| Quantity | 30 Tablets |
| Expiration Date | 2 Years or more |
| Type | Herbal |
| Country of Manufacturer | India |
Customer Reviews
You may also like
-5%
Original price was: $8.25.$7.85Current price is: $7.85.
-5%
Original price was: $14.15.$13.45Current price is: $13.45.
-5%
Original price was: $9.65.$9.15Current price is: $9.15.
-5%
Original price was: $8.70.$8.25Current price is: $8.25.
-5%
Original price was: $30.80.$29.25Current price is: $29.25.
-5%
Original price was: $7.75.$7.35Current price is: $7.35.
-5%
Original price was: $11.75.$11.15Current price is: $11.15.
-5%
Original price was: $10.30.$9.80Current price is: $9.80.
-5%
Original price was: $11.65.$11.05Current price is: $11.05.
-5%
Original price was: $9.50.$9.05Current price is: $9.05.
-5%
Original price was: $9.30.$8.85Current price is: $8.85.
-5%
Original price was: $16.50.$15.65Current price is: $15.65.
Reviews
There are no reviews yet.